Human RIG-I Antiviral Deficiency Caused by a Dominant-Negative Variant Trapped in a Signaling-Inactive State

Inside every human cell, a silent surveillance system constantly scans for signs of invasion. When a virus enters, it leaves behind a specific chemical signature on its genetic material, a tiny molecular flag that the cell's immune sentinels recognize as foreign. One of the most important of these sentinels is a protein called RIG-I. Its job is to spot this viral flag, grab onto it, and then sound a loud alarm that triggers the production of interferons, powerful signaling molecules that rally the body's defenses to fight off the infection. For this alarm to work, the protein must not only recognize the virus but also undergo a precise physical change, shifting its shape to expose the part of itself that sends the signal. If this shape-shifting fails, the alarm remains silent, and the virus can replicate unchecked.

Scientists have long known that when this protein malfunctions in a way that makes it too active, it can cause severe autoimmune diseases, where the body attacks itself. However, the opposite problem—a version of the protein that is broken and cannot sound the alarm at all—was a mystery. While researchers had found mutations that made RIG-I hyperactive, they had never identified a naturally occurring mutation in a human that simply turned the protein off, leaving the person vulnerable to deadly viral infections. Understanding how a protein can be broken in this specific way is crucial, because it reveals the exact mechanical steps required for our immune system to work. Without knowing these steps, we cannot fully understand why some people are uniquely susceptible to severe viral pneumonia while others are not.

A team of researchers recently solved this puzzle by studying a 63-year-old man who was hospitalized with life-threatening pneumonia caused by the SARS-CoV-2 virus. Despite having no other health issues, his immune system failed to respond to the infection. Genetic testing revealed that he carried a single, rare error in the gene that makes the RIG-I protein. This error changed a tiny building block of the protein, swapping a small, neutral piece for a large, charged one. In the language of biology, this is a substitution of the amino acid glycine with arginine at position 731. The researchers discovered that this single change created a "dominant-negative" effect, meaning the broken protein did not just fail to work; it actively sabotaged the healthy proteins in the cell, preventing them from doing their job.

To understand how this happened, the scientists recreated the situation in the laboratory. They grew immune cells from the patient and found that when these cells were exposed to viral RNA, they produced almost no interferon, the chemical alarm. In contrast, cells from healthy people sounded the alarm immediately. The researchers then built a model system using cells that lacked the RIG-I protein entirely and added back either the healthy version or the patient's broken version. The broken version, on its own, could not trigger any alarm. More importantly, when they mixed the broken version with the healthy version in the same cell, the healthy protein was silenced. The broken protein was acting like a blocker, crowding out the good ones and stopping the immune response entirely.

The team then looked closely at what the broken protein was actually doing. They found that the mutant protein was surprisingly good at its first job: it grabbed onto the viral RNA just as tightly as the healthy protein did. It also held onto ATP, the energy molecule cells use to power their movements. However, the moment it needed to use that energy to change its shape and send the signal, it got stuck. The mutation had trapped the protein in a half-formed state. It was holding the virus, but it was frozen in a position where the part of the protein responsible for sending the alarm remained hidden and inaccessible. Because it was stuck holding the virus, it prevented the healthy proteins from ever getting a chance to bind to the virus and start the signaling process.

This discovery overturned a common assumption in the field. Scientists had previously thought that if a protein could bind to a virus and hold onto it, it would eventually trigger an immune response, even if it was slow to do so. This study showed that binding is not enough. The protein must be able to complete a specific mechanical transition, a shift from an initial grip to a fully engaged state, to function. The researchers tested this by creating other versions of the protein with different changes at the same spot. When they replaced the small piece with a slightly larger but neutral piece, the protein actually became hyperactive, sounding the alarm even without a virus present. This proved that the exact size and shape of the building block at this specific spot act as a precise switch, controlling whether the protein stays quiet, sounds the alarm, or gets stuck.

The researchers used advanced imaging techniques to watch how the protein moved and changed shape. They saw that the healthy protein, when it found a virus, would close its hands around the genetic material and then shift its internal structure to expose the alarm signal. The broken protein, however, would grab the virus but then fail to close its hands properly. It remained in an open, unstable state that could not send a signal. This state was so stable that the protein refused to let go of the virus, effectively clogging the system. The study also showed that the part of the protein that usually keeps it quiet until it finds a virus was the very thing that kept the broken version stuck. When the researchers removed this "brake" from the broken protein, it regained some ability to signal, confirming that the mutation had locked the protein in a specific, inactive pose.

This work provides a clear explanation for why the patient was so severely affected by the virus. His immune system was not missing the ability to detect the virus; it was being actively suppressed by a single defective protein that hijacked the cellular machinery. The findings highlight that the immune system relies on a delicate balance of physical movements, and that a tiny error in the shape of a single protein can have catastrophic consequences. It also demonstrates that the same spot on a protein can be tuned to produce completely different outcomes depending on the exact nature of the change, acting as a finely calibrated regulator of human health. By identifying this specific mechanism, the study offers a new target for understanding immune deficiencies and suggests that future treatments might need to focus on unlocking these stuck proteins rather than just boosting the immune system in general.